Neuronetics, Inc. Cash and Restricted Cash
Neuronetics, Inc. (STIM) had Cash and Restricted Cash of $24.95 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-11
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $24.95M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18.96M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $34.13M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $34.47M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $24.95M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $18.96M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $34.13M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $34.47M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $17.47M 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $21.22M 10-Q · filed 2026-05-05 | |
| 2024-12-31 | $19.46M 10-Q · filed 2026-08-11 | |
| 2024-09-30 | $20.87M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $42.64M 10-Q · filed 2025-08-05 | |
| 2024-03-31 | $47.73M 10-Q · filed 2025-05-06 | |
| 2023-12-31 | $59.68M 10-K · filed 2026-03-17 | |
| 2023-09-30 | $812.29K 8-K/A · filed 2025-02-06 | $35.85M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $45.91M 10-Q · filed 2024-08-12 | |
| 2023-03-31 | $55.44M 10-Q · filed 2024-05-07 | |
| 2022-12-31 | $70.34M 10-K · filed 2026-03-17 | |
| 2022-09-30 | $73.70M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $70.93M 10-Q · filed 2023-08-08 | |
| 2022-03-31 | $80.84M 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $94.14M 10-K · filed 2025-03-27 | |
| 2021-09-30 | $99.43M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $115.78M 10-Q · filed 2022-08-02 | |
| 2021-03-31 | $121.28M 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $48.96M 10-K · filed 2024-03-08 | |
| 2020-09-30 | $50.72M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $54.00M 10-Q · filed 2021-08-03 | |
| 2020-03-31 | $63.65M 10-Q · filed 2021-05-04 | |
| 2019-12-31 | $75.71M 10-K · filed 2023-03-07 | |
| 2019-09-30 | $82.37M 10-Q · filed 2020-11-02 | |
| 2019-06-30 | $89.64M 10-Q · filed 2020-08-04 | |
| 2019-03-31 | $96.15M 10-Q · filed 2020-05-05 | |
| 2018-12-31 | $104.58M 10-K · filed 2022-03-08 | |
| 2018-09-30 | $106.76M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $14.54M 10-Q · filed 2019-08-06 | |
| 2018-03-31 | $20.35M 10-Q · filed 2019-05-07 | |
| 2017-12-31 | $29.15M 10-K · filed 2021-03-02 | |
| 2017-09-30 | $24.15M 10-Q · filed 2018-11-06 | |
| 2016-12-31 | $17.04M 10-K · filed 2020-03-03 | |
| 2015-12-31 | $21.01M 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |